Oleksandr Bilovol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oleksandr Bilovol has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Anna Shalimova
Kharkiv National Medical University, Kharkiv, Ukraine
5 shared publications - I. P. Dunaieva
Kharkiv National Medical University
5 shared publications Lesya Bobronnikova
5 shared publications- Iryna Ivanivna Knyazkova
Kharkiv National Medical University, Kharkiv, Ukraine
4 shared publications - Ruslan V. Lutsenko
POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE
3 shared publications Anna Shalimova
The Government Institution ‘L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine’, Kharkiv, Ukraine; Kharkiv National Medical University, Kharkiv, Ukraine
2 shared publications
Latest Publications
- 30 September 2025
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Problems of Cryobiology and Cryomedicine
- Vol. 35 (3) , 157-162
The impact of indoline derivatives on the carbohydrate metabolism of rats within a cold stress model
This study investigated the protective effect of 2-oxoindoline-3-glyoxylic acid derivatives and its mechanisms upon cold injury in rats. The protective activity of 13 newly synthesized 2-oxoindoline-3-glyoxylic acid derivatives was evaluated at a dose of 12 mg/kg body weight administered intraperitoneally. One hour after administration, the physical endurance of male rats was assessed under cold stress conditions (water temperature +10 °C) with an additional load (10% of body weight) by measuring the duration of swimming (in seconds) until the appearance of complete fatigue (immersion). The results were compared to those of the reference substance ethylthiobenzimidazole at a dose of 50 mg/kg. The most effective results were observed after the administration of 2-hydroxy-2-(5-methyl-2-oxy-1,2-dihydroindol-3-ylidene)-N-phenylacetamide. In animals, serum glucose levels and carbohydrate metabolism indicators in hepatocytes (glycogen, glucose, pyruvate, lactate content and their ratio) were determined. It was established that administering 2-hydroxy-2-(5-methyl-2-oxy-1,2-dihydroindol-3-ylidene)-N-phenylacetamide significantly prolonged the duration of swimming in cold water, compared to both the control group and the group administered ethylthiobenzimidazole. Under hypothermic conditions, this compound prevented hypoglycaemia and positively affected carbohydrate metabolism in the liver, as evidenced by preserved glycogen, glucose and pyruvate content, and increased lactate levels.
- 30 September 2025
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Problems of Cryobiology and Cryomedicine
- Vol. 35 (3) , 157-162
The impact of indoline derivatives on the carbohydrate metabolism of rats within a cold stress model
This study investigated the protective effect of 2-oxoindoline-3-glyoxylic acid derivatives and its mechanisms upon cold injury in rats. The protective activity of 13 newly synthesized 2-oxoindoline-3-glyoxylic acid derivatives was evaluated at a dose of 12 mg/kg body weight administered intraperitoneally. One hour after administration, the physical endurance of male rats was assessed under cold stress conditions (water temperature +10 °C) with an additional load (10% of body weight) by measuring the duration of swimming (in seconds) until the appearance of complete fatigue (immersion). The results were compared to those of the reference substance ethylthiobenzimidazole at a dose of 50 mg/kg. The most effective results were observed after the administration of 2-hydroxy-2-(5-methyl-2-oxy-1,2-dihydroindol-3-ylidene)-N-phenylacetamide. In animals, serum glucose levels and carbohydrate metabolism indicators in hepatocytes (glycogen, glucose, pyruvate, lactate content and their ratio) were determined. It was established that administering 2-hydroxy-2-(5-methyl-2-oxy-1,2-dihydroindol-3-ylidene)-N-phenylacetamide significantly prolonged the duration of swimming in cold water, compared to both the control group and the group administered ethylthiobenzimidazole. Under hypothermic conditions, this compound prevented hypoglycaemia and positively affected carbohydrate metabolism in the liver, as evidenced by preserved glycogen, glucose and pyruvate content, and increased lactate levels.
- Open Access
- 30 April 2025
- Published by Poltava State Medical University (PSMU) in The Medical and Ecological Problems
- Vol. 29 (1) , 19-25
EPIDEMIOLOGY OF HYPERTENSIVE DISEASE DURING ARMED CONFLICT IN A FRONTLINE CITY
The aim of this research is to examine the prevalence and incidence of hypertension and related cardiovascular complications, such as acute myocardial infarction and stroke, among the adult population of Kharkiv during the armed conflict in 2022–2023, and to assess their impact on cardiovascular health. Materials and methods. The study relied on data from the Information and Analytical Center for Medical Statistics, focusing on incidence rates of hypertension, acute myocardial infarction, and stroke among the population of Kharkiv from 2021 to 2023. The analysis was carried out using standardized epidemiological methods and uniform diagnostic criteria. Results. The analysis of hypertension prevalence rates per 100,000 population in Kharkiv for 2022 and 2023 revealed an overall increase of 9.5%, with a 9.9% rise among men and a 9.25% rise among women. Furthermore, the incidence of hypertension (per 100,000 adult population) increased by 25.3% overall during the same period, with a significant 47.4% increase among men and a 13.5% increase among women. The analysis of acute myocardial infarction incidence per 100,000 adult population in Kharkiv for 2022 and 2023 showed an increase of 20.4% in 2023. When comparing data between men and women, it was found that the incidence of acute myocardial infarction (per 100,000 adult population) in Kharkiv increased by 26.7% among men and by 11.8% among women. Similarly, the incidence of stroke per 100,000 adult population increased by 13.9% overall between 2022 and 2023. When analyzing stroke incidence per 100,000 adult population in Kharkiv for 2022 and 2023, an increase of 21.8% was observed among men and 5.6% among women. Thus, under the conditions of armed conflict, the prevalence of arterial hypertension (AH) has increased, with a notably higher rise observed among men. In addition, there has been a marked increase in the incidence of cardiovascular complications, particularly acute myocardial infarction and stroke.
- 30 April 2025
- Published by Poltava State Medical University (PSMU) in The Medical and Ecological Problems
- Vol. 29 (1) , 19-25
Open AccessEPIDEMIOLOGY OF HYPERTENSIVE DISEASE DURING ARMED CONFLICT IN A FRONTLINE CITY
The aim of this research is to examine the prevalence and incidence of hypertension and related cardiovascular complications, such as acute myocardial infarction and stroke, among the adult population of Kharkiv during the armed conflict in 2022–2023, and to assess their impact on cardiovascular health. Materials and methods. The study relied on data from the Information and Analytical Center for Medical Statistics, focusing on incidence rates of hypertension, acute myocardial infarction, and stroke among the population of Kharkiv from 2021 to 2023. The analysis was carried out using standardized epidemiological methods and uniform diagnostic criteria. Results. The analysis of hypertension prevalence rates per 100,000 population in Kharkiv for 2022 and 2023 revealed an overall increase of 9.5%, with a 9.9% rise among men and a 9.25% rise among women. Furthermore, the incidence of hypertension (per 100,000 adult population) increased by 25.3% overall during the same period, with a significant 47.4% increase among men and a 13.5% increase among women. The analysis of acute myocardial infarction incidence per 100,000 adult population in Kharkiv for 2022 and 2023 showed an increase of 20.4% in 2023. When comparing data between men and women, it was found that the incidence of acute myocardial infarction (per 100,000 adult population) in Kharkiv increased by 26.7% among men and by 11.8% among women. Similarly, the incidence of stroke per 100,000 adult population increased by 13.9% overall between 2022 and 2023. When analyzing stroke incidence per 100,000 adult population in Kharkiv for 2022 and 2023, an increase of 21.8% was observed among men and 5.6% among women. Thus, under the conditions of armed conflict, the prevalence of arterial hypertension (AH) has increased, with a notably higher rise observed among men. In addition, there has been a marked increase in the incidence of cardiovascular complications, particularly acute myocardial infarction and stroke.
- Open Access
- 29 December 2023
- Published by Poltava State Medical University (PSMU) in The Medical and Ecological Problems
- Vol. 27 (5-6) , 13-18
THE INFLUENCE OF 2-OXOINDOLINE-3-GLYOXYLIC ACID DERIVATIVES ON THE NEUROPHYSIOLOGICAL REACTIONS OF RATS IN THE “BLACK AND WHITE CHAMBER” TEST
The number of patients with an anxiety pathology is constantly growing, which requires the search and development of new remedies for protection. The aim of this research is to establish the presence of anxiolytic activity in derivatives of 2-oxoindolin-3-glyoxylic acid basedon testing animals in the “black-and-white chamber” test. Materials and methods. Experiments were performed on 150 adult male rats. The 2-oxoindoline derivatives were suspended ex tempore (water for injection and Tween-80) and administered to rats at a dose of 12 mg/kg intraperitoneally 1 hour before testing. The control group received a solvent with an emulsifier. Diazepam (2 mg/kg) served as a reference preparation. Behavior was studied in the “black and white chamber” test. Results. Compound 2 significantly reduced the residence time in the light compartment of the chamber. Substance 18 reduced the latent period of the first peek by 1.4 times (p<0.01), significantly increased the number and time of peeking, reduced the latent period of exit by 1.6 times (p<0.001), increased the number of exits and the time spent in the illuminated part of the device and significantly increased the percentage of rats peeking or exiting from the dark compartment and also reduced the number of boluses by 1.9-fold (p<0.001) compared to the control. Substance 2-T only increased the total time of peeking, compound K significantly reduced the number of boluses, and compound 3.85 increased the latent period of the first peek by 1.5 times (p<0.002), substance G increased the number of peeks by 1.7 times ( p<0.05), the time of stay in the light compartment of the camera by 2.5 times (p<0.001) and reduced the number of boluses by 1.3 times compared to the injection control (p<0.05). Conclusion. Administration of the IK compound significantly prolonged the latency of the first peek and exit, as well as significantly reduced the number of boluses compared to the control. 100% of animals peeked into the illuminated compartment of the chamber. Derivatives of 2-oxoindoline with the laboratory codes 18, G, and IК changed the neurophysiological reactions of animals in a similar way to the classic anxiolytic diazepam.
- 29 December 2023
- Published by Poltava State Medical University (PSMU) in The Medical and Ecological Problems
- Vol. 27 (5-6) , 13-18
Open AccessTHE INFLUENCE OF 2-OXOINDOLINE-3-GLYOXYLIC ACID DERIVATIVES ON THE NEUROPHYSIOLOGICAL REACTIONS OF RATS IN THE “BLACK AND WHITE CHAMBER” TEST
The number of patients with an anxiety pathology is constantly growing, which requires the search and development of new remedies for protection. The aim of this research is to establish the presence of anxiolytic activity in derivatives of 2-oxoindolin-3-glyoxylic acid basedon testing animals in the “black-and-white chamber” test. Materials and methods. Experiments were performed on 150 adult male rats. The 2-oxoindoline derivatives were suspended ex tempore (water for injection and Tween-80) and administered to rats at a dose of 12 mg/kg intraperitoneally 1 hour before testing. The control group received a solvent with an emulsifier. Diazepam (2 mg/kg) served as a reference preparation. Behavior was studied in the “black and white chamber” test. Results. Compound 2 significantly reduced the residence time in the light compartment of the chamber. Substance 18 reduced the latent period of the first peek by 1.4 times (p<0.01), significantly increased the number and time of peeking, reduced the latent period of exit by 1.6 times (p<0.001), increased the number of exits and the time spent in the illuminated part of the device and significantly increased the percentage of rats peeking or exiting from the dark compartment and also reduced the number of boluses by 1.9-fold (p<0.001) compared to the control. Substance 2-T only increased the total time of peeking, compound K significantly reduced the number of boluses, and compound 3.85 increased the latent period of the first peek by 1.5 times (p<0.002), substance G increased the number of peeks by 1.7 times ( p<0.05), the time of stay in the light compartment of the camera by 2.5 times (p<0.001) and reduced the number of boluses by 1.3 times compared to the injection control (p<0.05). Conclusion. Administration of the IK compound significantly prolonged the latency of the first peek and exit, as well as significantly reduced the number of boluses compared to the control. 100% of animals peeked into the illuminated compartment of the chamber. Derivatives of 2-oxoindoline with the laboratory codes 18, G, and IК changed the neurophysiological reactions of animals in a similar way to the classic anxiolytic diazepam.
- Open Access
- 15 September 2023
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 80 (3) , 23-31
DIAGNOSTIC AND PROGNOSTIC VALUE OF Β2-MICROGLOBULIN IN THE DEVELOPMENT OF CARDIORENAL SYNDROME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ARTERIAL HYPERTENSION
Arterial hypertension is the largest pandemic in the history of mankind, which defines the structure of cardiovascular morbidity and mortality. Currently, the correlation between hypertension and various pathological conditions and diseases has been proven, which largely determines its progression and contributes to the development of cardiovascular and renal complications. These diseases include type 2 diabetes mellitus, which is spreading globally as a pandemic. The history of arterial hypertension in combination with type 2 diabetes mellitus is often accompanied by the development of cardiorenal syndrome, so it is crucial to diagnose renal dysfunction and prevent cardiovascular complications in such patients. One of these biomarkers is β2-microglobulin (β2-M), which depends on the glomerular filtration rate and tubular reabsorption. Materials and methods. 90 patients with AH (men/women – 48/42) and 20 control subjects were examined. During a thorough examination and follow-up of patients, they were classified into 3 groups: patients with AH – group 1 – 31 people; group 2 – AH in combination with T2DM – 31 people; group 3 – patients with AH, T2DM, and obesity – 28 people. Body weight and height were measured in all patients, and BMI = body weight/height2 (m2) was calculated. The β2-microglobulin levels in the patients' serum, cardiotrophin-1, catestatin, leptin, cystatin C, neutrophil gelatinase-associated lipocalin, and N-terminal pro-brain natriuretic peptide, 25-OH total vitamin D, serum insulin levels, glycosylated hemoglobin, lipid metabolism, and systolic and diastolic blood pressure were measured. Statistical data analysis was performed using Statistica, 12 (Stat Soft Inc, USA) and Microsoft Office Excel 2013. The data are presented as mean (M) and standard deviation (δ). Differences between groups of mean values were evaluated using the Student's t-test. Results and conclusions. The level of β2-M in the observed groups of patients differed significantly from that of healthy individuals. An increase in β2-M concentration allowed us to confirm the presence of tubular renal dysfunction, which was not diagnosed by conventional methods. All examined patients were divided into 2 groups depending on the β2-M level. Our data prove the role of β2-microglobulin as an independent biomarker of renal dysfunction, as well as the development of early cardiovascular complications. The data obtained from the mathematical models between creatinine and β2-microglobulin, urea and β2-microglobulin levels show a highly significant correlation between β2-microglobulin and renal function and demonstrate that β2-microglobulin is an independent factor in the prediction of renal dysfunction in patients with hypertension and concomitant type 2 diabetes mellitus. β2-microglobulin is a biomarker that should be used in the diagnosis and prognosis of early manifestations of cardiorenal syndrome.
- 15 September 2023
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 80 (3) , 23-31
Open AccessDIAGNOSTIC AND PROGNOSTIC VALUE OF Β2-MICROGLOBULIN IN THE DEVELOPMENT OF CARDIORENAL SYNDROME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ARTERIAL HYPERTENSION
Arterial hypertension is the largest pandemic in the history of mankind, which defines the structure of cardiovascular morbidity and mortality. Currently, the correlation between hypertension and various pathological conditions and diseases has been proven, which largely determines its progression and contributes to the development of cardiovascular and renal complications. These diseases include type 2 diabetes mellitus, which is spreading globally as a pandemic. The history of arterial hypertension in combination with type 2 diabetes mellitus is often accompanied by the development of cardiorenal syndrome, so it is crucial to diagnose renal dysfunction and prevent cardiovascular complications in such patients. One of these biomarkers is β2-microglobulin (β2-M), which depends on the glomerular filtration rate and tubular reabsorption. Materials and methods. 90 patients with AH (men/women – 48/42) and 20 control subjects were examined. During a thorough examination and follow-up of patients, they were classified into 3 groups: patients with AH – group 1 – 31 people; group 2 – AH in combination with T2DM – 31 people; group 3 – patients with AH, T2DM, and obesity – 28 people. Body weight and height were measured in all patients, and BMI = body weight/height2 (m2) was calculated. The β2-microglobulin levels in the patients' serum, cardiotrophin-1, catestatin, leptin, cystatin C, neutrophil gelatinase-associated lipocalin, and N-terminal pro-brain natriuretic peptide, 25-OH total vitamin D, serum insulin levels, glycosylated hemoglobin, lipid metabolism, and systolic and diastolic blood pressure were measured. Statistical data analysis was performed using Statistica, 12 (Stat Soft Inc, USA) and Microsoft Office Excel 2013. The data are presented as mean (M) and standard deviation (δ). Differences between groups of mean values were evaluated using the Student's t-test. Results and conclusions. The level of β2-M in the observed groups of patients differed significantly from that of healthy individuals. An increase in β2-M concentration allowed us to confirm the presence of tubular renal dysfunction, which was not diagnosed by conventional methods. All examined patients were divided into 2 groups depending on the β2-M level. Our data prove the role of β2-microglobulin as an independent biomarker of renal dysfunction, as well as the development of early cardiovascular complications. The data obtained from the mathematical models between creatinine and β2-microglobulin, urea and β2-microglobulin levels show a highly significant correlation between β2-microglobulin and renal function and demonstrate that β2-microglobulin is an independent factor in the prediction of renal dysfunction in patients with hypertension and concomitant type 2 diabetes mellitus. β2-microglobulin is a biomarker that should be used in the diagnosis and prognosis of early manifestations of cardiorenal syndrome.
- Open Access
- 30 June 2023
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 19 (4) , 319-324
Catestatin in diagnosing cardiovascular and metabolic disorders in patients with comorbid hypertension
Background. Hypertension is the major pandemic in human history, which determines the structure of cardiovascular morbidity and mortality. There is an obvious relationship between hypertension and various diseases that largely determine its development and increase the risk of cardiovascular complications. Neuropeptides appear to have a major impact on the progression of these complications. Catestatin (CST) is one of them, which deserves special scientific and practical concern, as it has a wide range of biological effects in the body. The aim of the study: to determine the place of CST in the early diagnosis of cardiovascular and metabolic complications in patients with comorbid hypertension among the Ukrainian population. Materials and methods. One hundred and eleven patients with hypertension, type 2 diabetes mellitus, obesity (men/women — 50/61) and 20 controls were examined. All patients with hypertension, type 2 diabetes mellitus, and obesity were aged 54.37 ± 1.18 years. Following a thorough examination and supervision, they were divided into 2 groups depending on the median CST level of 2.45 ng/ml. The first group included 55 (49.5 %) patients who had a CST level below 2.45 ng/ml, the second one consisted of 56 patients (50.5 %) who had a CST level above 2.45 ng/ml. In all patients, we measured body weight, height, calculated body mass index, evaluated glycated hemoglobin levels, lipid metabolism (serum concentrations of total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein, and very low-density lipoprotein cholesterol); systolic and diastolic blood pressure. The content of CST, cardiotrophin 1, leptin, cystatin C, neutrophil gelatinase-associated lipocalin, N-terminal prohormone of brain natriuretic peptide, 25(OH)D, β2-microglobulin, and insulin levels in the blood serum were determined by enzyme-linked immunosorbent assay. Results. A reliable difference between the groups was found by β2-microglobulin (p = 0.008). Univariate and multivariate linear regression analysis revealed a negative correlation between CST and cardiotrophin 1, N-terminal prohormone of brain natriuretic peptide, neutrophil gelatinase-associated lipocalin, and 25(OH)D. A positive correlation was found between CST and the level of glycated hemoglobin, body mass index, and triglycerides. A statistically significant correlation was found between CST and creatinine (R = –0.21, p = 0.029), high-density lipoprotein cholesterol (R = 0.207, p = 0.029), and β2-microglobulin (R = 0.279, p = 0.0029) in the patients with hypertension. Conclusions. It has been proven that a decrease in serum catestatin concentration can be a risk factor for the development of more severe comorbidities in patients with hypertension. The detected relationships of catestatin with creatinine, urea, and β2-microglobulin suggest that CST is a predictor of chronic kidney disease in patients with comorbidities. The revealed correlation of CST with high-density lipoprotein, obesity, and body mass index suggests its importance in the prevention of atherosclerotic and metabolic complications in patients with hypertension, type 2 diabetes mellitus, and obesity.
- 30 June 2023
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 19 (4) , 319-324
Open AccessCatestatin in diagnosing cardiovascular and metabolic disorders in patients with comorbid hypertension
Background. Hypertension is the major pandemic in human history, which determines the structure of cardiovascular morbidity and mortality. There is an obvious relationship between hypertension and various diseases that largely determine its development and increase the risk of cardiovascular complications. Neuropeptides appear to have a major impact on the progression of these complications. Catestatin (CST) is one of them, which deserves special scientific and practical concern, as it has a wide range of biological effects in the body. The aim of the study: to determine the place of CST in the early diagnosis of cardiovascular and metabolic complications in patients with comorbid hypertension among the Ukrainian population. Materials and methods. One hundred and eleven patients with hypertension, type 2 diabetes mellitus, obesity (men/women — 50/61) and 20 controls were examined. All patients with hypertension, type 2 diabetes mellitus, and obesity were aged 54.37 ± 1.18 years. Following a thorough examination and supervision, they were divided into 2 groups depending on the median CST level of 2.45 ng/ml. The first group included 55 (49.5 %) patients who had a CST level below 2.45 ng/ml, the second one consisted of 56 patients (50.5 %) who had a CST level above 2.45 ng/ml. In all patients, we measured body weight, height, calculated body mass index, evaluated glycated hemoglobin levels, lipid metabolism (serum concentrations of total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein, and very low-density lipoprotein cholesterol); systolic and diastolic blood pressure. The content of CST, cardiotrophin 1, leptin, cystatin C, neutrophil gelatinase-associated lipocalin, N-terminal prohormone of brain natriuretic peptide, 25(OH)D, β2-microglobulin, and insulin levels in the blood serum were determined by enzyme-linked immunosorbent assay. Results. A reliable difference between the groups was found by β2-microglobulin (p = 0.008). Univariate and multivariate linear regression analysis revealed a negative correlation between CST and cardiotrophin 1, N-terminal prohormone of brain natriuretic peptide, neutrophil gelatinase-associated lipocalin, and 25(OH)D. A positive correlation was found between CST and the level of glycated hemoglobin, body mass index, and triglycerides. A statistically significant correlation was found between CST and creatinine (R = –0.21, p = 0.029), high-density lipoprotein cholesterol (R = 0.207, p = 0.029), and β2-microglobulin (R = 0.279, p = 0.0029) in the patients with hypertension. Conclusions. It has been proven that a decrease in serum catestatin concentration can be a risk factor for the development of more severe comorbidities in patients with hypertension. The detected relationships of catestatin with creatinine, urea, and β2-microglobulin suggest that CST is a predictor of chronic kidney disease in patients with comorbidities. The revealed correlation of CST with high-density lipoprotein, obesity, and body mass index suggests its importance in the prevention of atherosclerotic and metabolic complications in patients with hypertension, type 2 diabetes mellitus, and obesity.
- Open Access
- 14 June 2023
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 80 (2) , 7-13
DEPENDENCE OF CARDIOTROPHIN-1 ON BIOCHEMICAL AND HORMONAL FACTORS IN PATIENTS WITH COMORBID PATHOLOGY: ARTERIAL HYPERTENSION, DIABETES MELLITUS TYPE 2 AND OBESITY
The prevalence of arterial hypertension, type 2 diabetes mellitus (type 2 DM), and obesity is constantly increasing worldwide. Today, a complex of factors, which primarily include chronic emotional stress, pandemics of infectious diseases, military conflicts, have led to a significant increase in chronic non-communicable diseases. The aim of the study. To determine the dependence of Cardiotrophin-1 on a number of biochemical and hormonal indicators in patients with arterial hypertension, type 2 DM, and obesity, representatives of the Ukrainian population. Materials and methods. The study included 211 patients aged 49 to 65 years, who were divided into groups depending on the pathology: patients with arterial hypertension – 49 persons, Group I; patients with arterial hypertension in combination with class 1 obesity – 54 persons, Group 2; patients with arterial hypertension in combination with type 2 DM – 57 persons, Group 3; patients with arterial hypertension, type 2 DM, class 1 obesity – 51 persons, Group 4; as well as 20 persons – the Control group. Determination of the content of Cardiotrophin-1, catestatin, leptin, cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), N-terminal brain natriuretic peptide (NT-proBNP), 25-OH of common vitamin D (Vitamin D3), blood levels was carried out by enzyme immunoassay on Labline-90 analyzer (Austria), using commercial test systems manufactured by FineTest (ELISA, China), BT LAB (ELISA, China), DBC (ELISA, China), Elabscience (ELISA, Canada), Monobind Inc. (ELISA, USA). Statistical data analysis was performed, using the statistical software package Statistica, 12 (Stat Soft Inc, USA), Microsoft Office Excel 2013. Data are shown as mean (M) and standard deviations (δ). An error of less than 5% was considered to be significant (pResults. Thus, the study indicates that comorbid patients with arterial hypertension, type 2 DM, and obesity are predicted to develop complications from the cardiovascular system and Cardiotrophin-1 is a marker of their development. In the examined patients as a whole, the level of Cardiotrophin-1 is closely related to the peptide-hormonal complex: catestatin, leptin, cystatin C, brain natriuretic peptide, and lipocalin associated with neutrophil gelatinase. Conclusions: The serum concentration of Cardiotrophin-1 in patients with arterial hypertension increases significantly in a progression with the rate of accession of comorbid pathology and its severity. The Cardiotrophin-1 level in patients with comorbid pathology is affected by catestatin, leptin, cystatin C, NT-pro BNP, as well as the level of triglycerides, HDL-C, creatinine, and BMI. Cardiotrophin-1 can be considered as a universal biomarker for the development and progression of cardiovascular disorders in patients with comorbid pathology of arterial hypertension, type 2 DM, and obesity.
- 14 June 2023
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 80 (2) , 7-13
Open AccessDEPENDENCE OF CARDIOTROPHIN-1 ON BIOCHEMICAL AND HORMONAL FACTORS IN PATIENTS WITH COMORBID PATHOLOGY: ARTERIAL HYPERTENSION, DIABETES MELLITUS TYPE 2 AND OBESITY
The prevalence of arterial hypertension, type 2 diabetes mellitus (type 2 DM), and obesity is constantly increasing worldwide. Today, a complex of factors, which primarily include chronic emotional stress, pandemics of infectious diseases, military conflicts, have led to a significant increase in chronic non-communicable diseases. The aim of the study. To determine the dependence of Cardiotrophin-1 on a number of biochemical and hormonal indicators in patients with arterial hypertension, type 2 DM, and obesity, representatives of the Ukrainian population. Materials and methods. The study included 211 patients aged 49 to 65 years, who were divided into groups depending on the pathology: patients with arterial hypertension – 49 persons, Group I; patients with arterial hypertension in combination with class 1 obesity – 54 persons, Group 2; patients with arterial hypertension in combination with type 2 DM – 57 persons, Group 3; patients with arterial hypertension, type 2 DM, class 1 obesity – 51 persons, Group 4; as well as 20 persons – the Control group. Determination of the content of Cardiotrophin-1, catestatin, leptin, cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), N-terminal brain natriuretic peptide (NT-proBNP), 25-OH of common vitamin D (Vitamin D3), blood levels was carried out by enzyme immunoassay on Labline-90 analyzer (Austria), using commercial test systems manufactured by FineTest (ELISA, China), BT LAB (ELISA, China), DBC (ELISA, China), Elabscience (ELISA, Canada), Monobind Inc. (ELISA, USA). Statistical data analysis was performed, using the statistical software package Statistica, 12 (Stat Soft Inc, USA), Microsoft Office Excel 2013. Data are shown as mean (M) and standard deviations (δ). An error of less than 5% was considered to be significant (pResults. Thus, the study indicates that comorbid patients with arterial hypertension, type 2 DM, and obesity are predicted to develop complications from the cardiovascular system and Cardiotrophin-1 is a marker of their development. In the examined patients as a whole, the level of Cardiotrophin-1 is closely related to the peptide-hormonal complex: catestatin, leptin, cystatin C, brain natriuretic peptide, and lipocalin associated with neutrophil gelatinase. Conclusions: The serum concentration of Cardiotrophin-1 in patients with arterial hypertension increases significantly in a progression with the rate of accession of comorbid pathology and its severity. The Cardiotrophin-1 level in patients with comorbid pathology is affected by catestatin, leptin, cystatin C, NT-pro BNP, as well as the level of triglycerides, HDL-C, creatinine, and BMI. Cardiotrophin-1 can be considered as a universal biomarker for the development and progression of cardiovascular disorders in patients with comorbid pathology of arterial hypertension, type 2 DM, and obesity.
- Open Access
- 15 March 2023
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 80 (1) , 30-35
АНАЛІЗ ПАРАМЕТРІВ ДІАСТОЛІЧНОЇ ДИСФУНКЦІЇ ЛІВОГО ШЛУНОЧКА У ХВОРИХ НА ГІПЕРТОНІЧНУ ХВОРОБУ З СУПУТНІМ ЦУКРОВИМ ДІАБЕТОМ 2 ТИПУ
Мета дослідження. Провести аналіз особливостей діастолічної функції лівого шлуночка у хворих на гіпертонічну хворобу з супутнім цукровим діабетом 2 типу та без нього до та після комплексного лікування з включенням еплеренону 50 мг на добу та триметазидину 80 мг на добу. Матеріали та методи дослідження. Обстежено 25 хворих на гіпертонічну хворобу (ГХ) та цукровий діабет 2 типу (ЦД2) в стані субкомпенсації (основна група) та 25 пацієнтів з ГХ II стадії без ЦД2 у віці від 35 до 65 років, що перебували на лікуванні в клініці ДУ «Національний інститут терапії імені Л.Т. Малої НАМН України». Контрольну групу склали 20 здорових осіб. Статистичний аналіз даних виконали за допомогою пакету статистичних програм Statistica 8.0 (Stat Soft Inc, США), Microsoft office Excel 2003, з використанням стандартних методів. Результати та висновки. Тримісячне лікування еплереноном і триметазидином сприяло нормалізації гемодинаміки і метаболічних процесів, призводило до покращення функціональних можливостей міокарду (підвищення швидкості розслаблення міокарду в діастолу), загальмування або припинення подальшого розвитку несприятливих змін кардіогемодинаміки у вигляді підвищення тиску наповнення лівого шлуночку та порушення геометричних параметрів серця. Вивчення параметрів діастолічної функції лівого шлуночка на етапі функціональних порушень міокарда необхідне з метою профілактики або зворотного розвитку серцевої недостатності у хворих на коморбідну патологію: гіпертонічну хворобу з супутнім цукровим діабетом 2 типу, що є запорукою поліпшення серцево-судинного прогнозу у такого контингенту пацієнтів. Проведене дослідження підтверджує необхідність своєчасної діагностики з метою уточнення механізмів розвитку серцевої недостатності у хворих з коморбідною патологією та проведення профілактичного лікування виявлених порушень за умов збереження стану субкомпенсації вуглеводного обміну.
- 15 March 2023
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 80 (1) , 30-35
Open AccessАНАЛІЗ ПАРАМЕТРІВ ДІАСТОЛІЧНОЇ ДИСФУНКЦІЇ ЛІВОГО ШЛУНОЧКА У ХВОРИХ НА ГІПЕРТОНІЧНУ ХВОРОБУ З СУПУТНІМ ЦУКРОВИМ ДІАБЕТОМ 2 ТИПУ
Мета дослідження. Провести аналіз особливостей діастолічної функції лівого шлуночка у хворих на гіпертонічну хворобу з супутнім цукровим діабетом 2 типу та без нього до та після комплексного лікування з включенням еплеренону 50 мг на добу та триметазидину 80 мг на добу. Матеріали та методи дослідження. Обстежено 25 хворих на гіпертонічну хворобу (ГХ) та цукровий діабет 2 типу (ЦД2) в стані субкомпенсації (основна група) та 25 пацієнтів з ГХ II стадії без ЦД2 у віці від 35 до 65 років, що перебували на лікуванні в клініці ДУ «Національний інститут терапії імені Л.Т. Малої НАМН України». Контрольну групу склали 20 здорових осіб. Статистичний аналіз даних виконали за допомогою пакету статистичних програм Statistica 8.0 (Stat Soft Inc, США), Microsoft office Excel 2003, з використанням стандартних методів. Результати та висновки. Тримісячне лікування еплереноном і триметазидином сприяло нормалізації гемодинаміки і метаболічних процесів, призводило до покращення функціональних можливостей міокарду (підвищення швидкості розслаблення міокарду в діастолу), загальмування або припинення подальшого розвитку несприятливих змін кардіогемодинаміки у вигляді підвищення тиску наповнення лівого шлуночку та порушення геометричних параметрів серця. Вивчення параметрів діастолічної функції лівого шлуночка на етапі функціональних порушень міокарда необхідне з метою профілактики або зворотного розвитку серцевої недостатності у хворих на коморбідну патологію: гіпертонічну хворобу з супутнім цукровим діабетом 2 типу, що є запорукою поліпшення серцево-судинного прогнозу у такого контингенту пацієнтів. Проведене дослідження підтверджує необхідність своєчасної діагностики з метою уточнення механізмів розвитку серцевої недостатності у хворих з коморбідною патологією та проведення профілактичного лікування виявлених порушень за умов збереження стану субкомпенсації вуглеводного обміну.
- Open Access
- 29 December 2022
- Published by Publishing House Zaslavsky in PAIN, JOINTS, SPINE
- Vol. 12 (4) , 195-200
Arterial stiffness in postmenopausal women with arterial hypertension
Background. It was established that the prevalence of reduced bone mineral density is significantly higher among patients with arterial hypertension compared to healthy subjects. The purpose of the research was to study arterial stiffness and central aortic pressure in women with arterial hypertension combined with osteoporosis. Materials and methods. 88 postmenopausal women with arterial hypertension (average age 62.7±3.8 years) were included in the study, of which 35 women with osteoporosis (OP) according to dual-energy X-ray absorptiometry (DXA) data (group 1) and 33 without it (group 2). The control group consisted of 20practically healthy women without arterial hypertension and OP. Before the start of the study, the patients did not regularly receive antihypertensive drugs. In addition to conventional studies, daily blood pressure monitoring, applanation tonometry, and DXA were performed. Statistical processing was performed using the Statistica 10.0 software package using standard variational statistics algorithms. Results. It was found that in group 1, the levels of office systolic (SBP) and diastolic blood pressure (DBP) were by 3.7 and 4.9% (p < 0.05) higher than in group 2. According to daily blood pressure monitoring, a more pronounced increase in average daily SBP and DBP by 4.1 and 6.6% (p < 0.05) was observed in group 1 compared to group 2. It was found that in group 1, compared to the control group and group 2, an increase in pulse wave velocity was detected by 37.2 and 26.4%, respectively. Conclusions. In women with postmenopausal osteoporosis in combination with arterial hypertension according to data of office measurement, daily monitoring blood pressure and data of applanation tonometry, blood pressure levels and parameters of arterial stiffness were significantly higher than in patients with arterial hypertension without osteoporosis.
- 29 December 2022
- Published by Publishing House Zaslavsky in PAIN, JOINTS, SPINE
- Vol. 12 (4) , 195-200
Open AccessArterial stiffness in postmenopausal women with arterial hypertension
Background. It was established that the prevalence of reduced bone mineral density is significantly higher among patients with arterial hypertension compared to healthy subjects. The purpose of the research was to study arterial stiffness and central aortic pressure in women with arterial hypertension combined with osteoporosis. Materials and methods. 88 postmenopausal women with arterial hypertension (average age 62.7±3.8 years) were included in the study, of which 35 women with osteoporosis (OP) according to dual-energy X-ray absorptiometry (DXA) data (group 1) and 33 without it (group 2). The control group consisted of 20practically healthy women without arterial hypertension and OP. Before the start of the study, the patients did not regularly receive antihypertensive drugs. In addition to conventional studies, daily blood pressure monitoring, applanation tonometry, and DXA were performed. Statistical processing was performed using the Statistica 10.0 software package using standard variational statistics algorithms. Results. It was found that in group 1, the levels of office systolic (SBP) and diastolic blood pressure (DBP) were by 3.7 and 4.9% (p < 0.05) higher than in group 2. According to daily blood pressure monitoring, a more pronounced increase in average daily SBP and DBP by 4.1 and 6.6% (p < 0.05) was observed in group 1 compared to group 2. It was found that in group 1, compared to the control group and group 2, an increase in pulse wave velocity was detected by 37.2 and 26.4%, respectively. Conclusions. In women with postmenopausal osteoporosis in combination with arterial hypertension according to data of office measurement, daily monitoring blood pressure and data of applanation tonometry, blood pressure levels and parameters of arterial stiffness were significantly higher than in patients with arterial hypertension without osteoporosis.
- Open Access
- 9 June 2022
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 79 (2) , 14-18
THE COURSE OF CHRONIC HEART FAILURE IN PERSONS WITH POST-INFARCTION CARDIOSCLEROSIS AND TYPE 2 DIABETES MELLITUS AND OBESITY ACCORDING TO A NUMBER OF METABOLIC AND HORMONAL INDICATORS
The aim of the study is to investigate the effect of lipid metabolism, biomarkers of fractalkin and clusterin inflammation on the development and progression of chronic heart failure in patients with post-infarction cardiosclerosis, type 2 diabetes and obesity. A retrospective analysis of a comprehensive examination of 67 patients with postinfarction cardiosclerosis with concomitant type 2 diabetes and obesity. All patients were divided into 3 groups depending on the functional class (FC) of CHF: 1 group (n = 22) - patients with CHF II FC; Group 2 (n = 23) - patients with CHF III FC; Group 3 (n = 22) - patients with CHF IV FC. All patients were examined clinically, they were instrumental, biochemical and hormonal examination. With the progression of CHF from FC II to FC III there is a deterioration of lipid metabolism: a significant increase in cholesterol levels by 5.5%, TG - by 15.7%, LDL cholesterol - by 74.4%, VLDL cholesterol - by 15 , 9%, reduction of HDL cholesterol - by 27.6% (p <0,05). An analysis of the fractal equation showing that ailing on CHF is advised by FC; rіven clusterin –decrease. Classical changes in patients with postinfarction cardiosclerosis with CHF and concomitant type 2 diabetes mellitus and obesity , which are the formation of atherogenic lipid metabolism disorders associated with body weight, as well as changes in the latest indicators such as fractalkin and clusterin , indicating the role of these molecules in the progression of CHF.
- 9 June 2022
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 79 (2) , 14-18
Open AccessTHE COURSE OF CHRONIC HEART FAILURE IN PERSONS WITH POST-INFARCTION CARDIOSCLEROSIS AND TYPE 2 DIABETES MELLITUS AND OBESITY ACCORDING TO A NUMBER OF METABOLIC AND HORMONAL INDICATORS
The aim of the study is to investigate the effect of lipid metabolism, biomarkers of fractalkin and clusterin inflammation on the development and progression of chronic heart failure in patients with post-infarction cardiosclerosis, type 2 diabetes and obesity. A retrospective analysis of a comprehensive examination of 67 patients with postinfarction cardiosclerosis with concomitant type 2 diabetes and obesity. All patients were divided into 3 groups depending on the functional class (FC) of CHF: 1 group (n = 22) - patients with CHF II FC; Group 2 (n = 23) - patients with CHF III FC; Group 3 (n = 22) - patients with CHF IV FC. All patients were examined clinically, they were instrumental, biochemical and hormonal examination. With the progression of CHF from FC II to FC III there is a deterioration of lipid metabolism: a significant increase in cholesterol levels by 5.5%, TG - by 15.7%, LDL cholesterol - by 74.4%, VLDL cholesterol - by 15 , 9%, reduction of HDL cholesterol - by 27.6% (p <0,05). An analysis of the fractal equation showing that ailing on CHF is advised by FC; rіven clusterin –decrease. Classical changes in patients with postinfarction cardiosclerosis with CHF and concomitant type 2 diabetes mellitus and obesity , which are the formation of atherogenic lipid metabolism disorders associated with body weight, as well as changes in the latest indicators such as fractalkin and clusterin , indicating the role of these molecules in the progression of CHF.
- Open Access
- 18 June 2021
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 26 (2) , 126-134
Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease
The aim of the study was to determine the relationship between the degree of progression of liver fibrosis and the risk of cardiovascular complications in patients with Type 2 diabetes mellitus (DM) with non-alcoholic fatty liver disease (NAFLD). The study included 110 patients with Type 2 diabetes (62 men and 48 women), the average age of the subjects was 52.07±1.11 years. All patients were divided into 2 groups: the main group included 72 patients with Type 2 diabetes with concomitant NAFLD (38 men and 34 women); the control group included 38 patients with Type 2 diabetes without clinical manifestations of NAFLD (24 men and 14 women). Patients of the main group were divided into 3 subgroups, taking into account the predominant pathological processes in the clinical picture. The division into subgroups was carried out in 2 stages: at the first stage, those with predominant manifestations of liver fibrosis (F2 or more) were selected from the general population of patients with Type 2 diabetes with NAFLD according to the results of liver elastography and the use of Bonacini and Metavir scales. The number of such patients was 29, which accounted for 40.3% of the total number of patients in the main group. The remaining patients were divided into 2 subgroups: 11 patients (15.3%) had non-alcoholic liver steatosis, and 32 patients (44.4%) had signs of non-alcoholic steatohepatitis (NASH). As a result of the study, it was found that the presence of liver fibrosis in patients with Type 2 diabetes with NAFLD is significantly more often associated with cardiovascular complications, such as arterial hypertension, coronary heart disease, myocardial infarction, stroke, diabetic retinopathy and nephropathy. A significant decrease in the ejection fraction (EF) was found in patients with Type 2 diabetes with concomitant NAFLD. At the same time, the number of patients with EF disorders of varying degrees in the main group significantly exceeded that in the comparison group (33.3% and 6.7%, respectively, p<0.001). The average values of left ventricular myocardial mass are significantly lower in patients with NASH and fibrosis formation compared to patients with NAFLD at the stage of fatty hepatosis. There was also a significant decrease in the size of the left and right atria in patients with NASH compared to both patients with steatosis and patients with fibrotic liver changes. Patients with predominant fibrotic changes in the liver are characterized by a relative decrease in myocardial mass, a decrease in final diastolic and systolic volumes and EF, which may indicate the development of diastolic dysfunction in them. It is shown that it is necessary to take into account in clinical practice not only the generally accepted stages of NAFLD, but also the predominant pathological process in the liver in patients with Type 2 diabetes, namely steatosis, manifestations of inflammation and fibrotic disorders. It is proved that fibrotic changes in the liver can develop at all stages of liver tissue damage.
- 18 June 2021
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 26 (2) , 126-134
Open AccessHepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease
The aim of the study was to determine the relationship between the degree of progression of liver fibrosis and the risk of cardiovascular complications in patients with Type 2 diabetes mellitus (DM) with non-alcoholic fatty liver disease (NAFLD). The study included 110 patients with Type 2 diabetes (62 men and 48 women), the average age of the subjects was 52.07±1.11 years. All patients were divided into 2 groups: the main group included 72 patients with Type 2 diabetes with concomitant NAFLD (38 men and 34 women); the control group included 38 patients with Type 2 diabetes without clinical manifestations of NAFLD (24 men and 14 women). Patients of the main group were divided into 3 subgroups, taking into account the predominant pathological processes in the clinical picture. The division into subgroups was carried out in 2 stages: at the first stage, those with predominant manifestations of liver fibrosis (F2 or more) were selected from the general population of patients with Type 2 diabetes with NAFLD according to the results of liver elastography and the use of Bonacini and Metavir scales. The number of such patients was 29, which accounted for 40.3% of the total number of patients in the main group. The remaining patients were divided into 2 subgroups: 11 patients (15.3%) had non-alcoholic liver steatosis, and 32 patients (44.4%) had signs of non-alcoholic steatohepatitis (NASH). As a result of the study, it was found that the presence of liver fibrosis in patients with Type 2 diabetes with NAFLD is significantly more often associated with cardiovascular complications, such as arterial hypertension, coronary heart disease, myocardial infarction, stroke, diabetic retinopathy and nephropathy. A significant decrease in the ejection fraction (EF) was found in patients with Type 2 diabetes with concomitant NAFLD. At the same time, the number of patients with EF disorders of varying degrees in the main group significantly exceeded that in the comparison group (33.3% and 6.7%, respectively, p<0.001). The average values of left ventricular myocardial mass are significantly lower in patients with NASH and fibrosis formation compared to patients with NAFLD at the stage of fatty hepatosis. There was also a significant decrease in the size of the left and right atria in patients with NASH compared to both patients with steatosis and patients with fibrotic liver changes. Patients with predominant fibrotic changes in the liver are characterized by a relative decrease in myocardial mass, a decrease in final diastolic and systolic volumes and EF, which may indicate the development of diastolic dysfunction in them. It is shown that it is necessary to take into account in clinical practice not only the generally accepted stages of NAFLD, but also the predominant pathological process in the liver in patients with Type 2 diabetes, namely steatosis, manifestations of inflammation and fibrotic disorders. It is proved that fibrotic changes in the liver can develop at all stages of liver tissue damage.